Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2022
SKU ID : QYR-19694453 | Publishing Date : 13-Dec-2021 | No. of pages : 107
Detailed TOC of Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AI Platfrom
1.2.3 Analytics Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence Drug R&D Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Discovery
1.3.3 Precision Medicine
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Drug R&D Market Perspective (2016-2027)
2.2 Artificial Intelligence Drug R&D Growth Trends by Regions
2.2.1 Artificial Intelligence Drug R&D Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Artificial Intelligence Drug R&D Historic Market Share by Regions (2016-2021)
2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Regions (2022-2027)
2.3 Artificial Intelligence Drug R&D Industry Dynamic
2.3.1 Artificial Intelligence Drug R&D Market Trends
2.3.2 Artificial Intelligence Drug R&D Market Drivers
2.3.3 Artificial Intelligence Drug R&D Market Challenges
2.3.4 Artificial Intelligence Drug R&D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue
3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2016-2021)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2016-2021)
3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2020
3.5 Artificial Intelligence Drug R&D Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Drug R&D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug R&D Breakdown Data by Type
4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2016-2021)
4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2022-2027)
5 Artificial Intelligence Drug R&D Breakdown Data by Application
5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2016-2021)
5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Artificial Intelligence Drug R&D Market Size (2016-2027)
6.2 North America Artificial Intelligence Drug R&D Market Size by Type
6.2.1 North America Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
6.2.2 North America Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
6.2.3 North America Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
6.3 North America Artificial Intelligence Drug R&D Market Size by Application
6.3.1 North America Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
6.3.2 North America Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
6.3.3 North America Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
6.4 North America Artificial Intelligence Drug R&D Market Size by Country
6.4.1 North America Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
6.4.2 North America Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Artificial Intelligence Drug R&D Market Size (2016-2027)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type
7.2.1 Europe Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
7.2.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
7.2.3 Europe Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application
7.3.1 Europe Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
7.3.2 Europe Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
7.3.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
7.4 Europe Artificial Intelligence Drug R&D Market Size by Country
7.4.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
7.4.2 Europe Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2016-2027)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type
8.2.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application
8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
8.4.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Drug R&D Market Size (2016-2027)
9.2 Latin America Artificial Intelligence Drug R&D Market Size by Type
9.2.1 Latin America Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
9.2.2 Latin America Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
9.2.3 Latin America Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
9.3 Latin America Artificial Intelligence Drug R&D Market Size by Application
9.3.1 Latin America Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
9.3.2 Latin America Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
9.3.3 Latin America Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country
9.4.1 Latin America Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
9.4.2 Latin America Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2016-2027)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type
10.2.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2016-2027)
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application
10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2016-2027)
10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
10.4.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IBM Watson
11.1.1 IBM Watson Company Details
11.1.2 IBM Watson Business Overview
11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.1.5 IBM Watson Recent Development
11.2 BioXel
11.2.1 BioXel Company Details
11.2.2 BioXel Business Overview
11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.2.5 BioXel Recent Development
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Details
11.3.2 Insilico Medicine Business Overview
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.3.5 Insilico Medicine Recent Development
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Details
11.4.2 Gatehouse Bio Business Overview
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.4.5 Gatehouse Bio Recent Development
11.5 Google DeepMind
11.5.1 Google DeepMind Company Details
11.5.2 Google DeepMind Business Overview
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.5.5 Google DeepMind Recent Development
11.6 Genpact Cora
11.6.1 Genpact Cora Company Details
11.6.2 Genpact Cora Business Overview
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.6.5 Genpact Cora Recent Development
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Details
11.7.2 Cyclica Inc Business Overview
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.7.5 Cyclica Inc Recent Development
11.8 QuantumBlack
11.8.1 QuantumBlack Company Details
11.8.2 QuantumBlack Business Overview
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.8.5 QuantumBlack Recent Development
11.9 Nq Medical
11.9.1 Nq Medical Company Details
11.9.2 Nq Medical Business Overview
11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.9.5 Nq Medical Recent Development
11.10 Phenomic AI
11.10.1 Phenomic AI Company Details
11.10.2 Phenomic AI Business Overview
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.10.5 Phenomic AI Recent Development
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Details
11.11.2 Palantir Technologies Business Overview
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2016-2021)
11.11.5 Palantir Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2022
List of TablesTable 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AI Platfrom
Table 3. Key Players of Analytics Service
Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Artificial Intelligence Drug R&D Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Artificial Intelligence Drug R&D Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Artificial Intelligence Drug R&D Market Share by Regions (2016-2021)
Table 8. Global Artificial Intelligence Drug R&D Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Artificial Intelligence Drug R&D Market Share by Regions (2022-2027)
Table 10. Artificial Intelligence Drug R&D Market Trends
Table 11. Artificial Intelligence Drug R&D Market Drivers
Table 12. Artificial Intelligence Drug R&D Market Challenges
Table 13. Artificial Intelligence Drug R&D Market Restraints
Table 14. Global Artificial Intelligence Drug R&D Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Artificial Intelligence Drug R&D Market Share by Players (2016-2021)
Table 16. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Intelligence Drug R&D as of 2020)
Table 17. Ranking of Global Top Artificial Intelligence Drug R&D Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Artificial Intelligence Drug R&D Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artificial Intelligence Drug R&D Product Solution and Service
Table 21. Date of Enter into Artificial Intelligence Drug R&D Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2016-2021)
Table 25. Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Artificial Intelligence Drug R&D Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2016-2021)
Table 29. Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2022-2027) & (US$ Million)
Table 61. IBM Watson Company Details
Table 62. IBM Watson Business Overview
Table 63. IBM Watson Artificial Intelligence Drug R&D Product
Table 64. IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 65. IBM Watson Recent Development
Table 66. BioXel Company Details
Table 67. BioXel Business Overview
Table 68. BioXel Artificial Intelligence Drug R&D Product
Table 69. BioXel Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 70. BioXel Recent Development
Table 71. Insilico Medicine Company Details
Table 72. Insilico Medicine Business Overview
Table 73. Insilico Medicine Artificial Intelligence Drug R&D Product
Table 74. Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 75. Insilico Medicine Recent Development
Table 76. Gatehouse Bio Company Details
Table 77. Gatehouse Bio Business Overview
Table 78. Gatehouse Bio Artificial Intelligence Drug R&D Product
Table 79. Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 80. Gatehouse Bio Recent Development
Table 81. Google DeepMind Company Details
Table 82. Google DeepMind Business Overview
Table 83. Google DeepMind Artificial Intelligence Drug R&D Product
Table 84. Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 85. Google DeepMind Recent Development
Table 86. Genpact Cora Company Details
Table 87. Genpact Cora Business Overview
Table 88. Genpact Cora Artificial Intelligence Drug R&D Product
Table 89. Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 90. Genpact Cora Recent Development
Table 91. Cyclica Inc Company Details
Table 92. Cyclica Inc Business Overview
Table 93. Cyclica Inc Artificial Intelligence Drug R&D Product
Table 94. Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 95. Cyclica Inc Recent Development
Table 96. QuantumBlack Company Details
Table 97. QuantumBlack Business Overview
Table 98. QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 99. QuantumBlack Recent Development
Table 100. Nq Medical Company Details
Table 101. Nq Medical Business Overview
Table 102. Nq Medical Artificial Intelligence Drug R&D Product
Table 103. Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 104. Nq Medical Recent Development
Table 105. Phenomic AI Company Details
Table 106. Phenomic AI Business Overview
Table 107. Phenomic AI Artificial Intelligence Drug R&D Product
Table 108. Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 109. Phenomic AI Recent Development
Table 110. Palantir Technologies Company Details
Table 111. Palantir Technologies Business Overview
Table 112. Palantir Technologies Artificial Intelligence Drug R&D Product
Table 113. Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2016-2021) & (US$ Million)
Table 114. Palantir Technologies Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Intelligence Drug R&D Market Share by Type: 2020 VS 2027
Figure 2. AI Platfrom Features
Figure 3. Analytics Service Features
Figure 4. Global Artificial Intelligence Drug R&D Market Share by Application: 2020 VS 2027
Figure 5. Drug Discovery Case Studies
Figure 6. Precision Medicine Case Studies
Figure 7. Artificial Intelligence Drug R&D Report Years Considered
Figure 8. Global Artificial Intelligence Drug R&D Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Artificial Intelligence Drug R&D Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Artificial Intelligence Drug R&D Market Share by Regions: 2020 VS 2027
Figure 11. Global Artificial Intelligence Drug R&D Market Share by Regions (2022-2027)
Figure 12. Global Artificial Intelligence Drug R&D Market Share by Players in 2020
Figure 13. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Intelligence Drug R&D as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2020
Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2016-2021)
Figure 16. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2022-2027)
Figure 17. North America Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
Figure 19. North America Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
Figure 20. North America Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
Figure 21. United States Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
Figure 25. Europe Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
Figure 26. Europe Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
Figure 27. Germany Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Region (2016-2027)
Figure 37. China Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
Figure 45. Latin America Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
Figure 46. Latin America Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
Figure 47. Mexico Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Country (2016-2027)
Figure 53. Turkey Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Artificial Intelligence Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. IBM Watson Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 57. BioXel Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 58. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 59. Gatehouse Bio Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 60. Google DeepMind Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 61. Genpact Cora Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 62. Cyclica Inc Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 63. QuantumBlack Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 64. Nq Medical Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 65. Phenomic AI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 66. Palantir Technologies Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2022
IBM WatsonBioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies